Startup & CFO Finance
Page content
Article list
88 articles on Startup & CFO Finance, authored by the Finin2min editorial team. Page 3 of 3.
Capitalising product cost can flatter EBITDA and assets. Auditors will ask whether it meets recognition criteria and whether benefits are demonstrable.
Before asking investors to trust your story, score your finance hygiene. Weak hygiene turns valuation into negotiation leverage for investors.
Grants feel like free money until conditions, utilisation certificates and accounting treatment arrive.
No founder wants to plan shutdown. But a controlled wind-down protects employees, investors, creditors and founders better than chaos.
D2C brands do not fail only because of bad products. They fail because returns, logistics and discounts quietly eat margin.
Startups lose money not only through fraud but through friendly chaos. A vendor approval matrix brings control without killing speed.
Venture debt feels less dilutive than equity, but it is not free money. It adds repayment, covenant and control pressure.
Zombie spend is the subscription, agency, headcount or project nobody owns but everyone pays for. ZBB forces every rupee to defend itself.
About this page
This page is one of a paginated set of index pages listing every article in Finin2min's Insights archive, ordered for browsing rather than grouped by subject - use the category pages (linked from the main Insights page) to browse by topic instead, or the search function for a specific question.
Disclaimer: This is an index/navigation page linking to Finin2min's own articles; it is not itself legal, tax or financial advice, and the linked articles should be checked against the current official source before reliance. Reviewed by Finin2min Editorial Desk · Last reviewed 3 September 2026.